Cargando…
MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
Active surveillance (AS) for prostate cancer (PCa) is generally considered to be a safe strategy for men with low-risk, localized disease. However, as many as 1 in 4 patients may be incorrectly classified as AS-eligible using traditional inclusion criteria. The use of multiparametric magnetic resona...
Autores principales: | Glaser, Zachary A., Porter, Kristin K., Thomas, John V., Gordetsky, Jennifer B., Rais-Bahrami, Soroush |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178314/ https://www.ncbi.nlm.nih.gov/pubmed/30363494 http://dx.doi.org/10.21037/tau.2018.03.21 |
Ejemplares similares
-
Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance
por: Glaser, Zachary A., et al.
Publicado: (2017) -
Personalized prostate cancer care
por: Rais-Bahrami, Soroush, et al.
Publicado: (2018) -
Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?
por: Rais-Bahrami, Soroush, et al.
Publicado: (2017) -
DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy
por: Dulaney, Caleb R., et al.
Publicado: (2017) -
Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
por: Gennaro, Kyle H., et al.
Publicado: (2018)